speb/financial-data huggingface dataset:
CXSE3.SA cash_flow (quarterly, 2025-12-31) — Change In Receivables: 2271000.00
CXSE3.SA cash_flow (annual, 2025-12-31) — Change In Working Capital: 61711000.00
CXSE3.SA cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 114531000.00
CXSE3.SA cash_flow (annual, 2025-12-31) — Changes In Cash: 7000.00
CXSE3.SA cash_flow (quarterly, 2025-12-31) — Changes In Cash: 238000.00
CXSE3.SA balance_sheet (annual, 2025-12-31) — Common Stock: 3678772000.00
CXSE3.SA balance_sheet (quarterly, 2025-12-31) — Common Stock: 3678772000.00
CXSE3.SA cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -3241014000.00
CXSE3.SA cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -415546000.00
CXSE3.SA balance_sheet (annual, 2025-12-31) — Common Stock Equity: 13550484000.00
CXSE3.SA balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 13550484000.00
CXSE3.SA balance_sheet (annual, 2025-12-31) — Current Deferred Taxes Liabilities: 499000.00
CXSE3.SA balance_sheet (quarterly, 2025-12-31) — Current Deferred Taxes Liabilities: 499000.00
CXSE3.SA cash_flow (annual, 2025-12-31) — Deferred Tax: 35000.00
CXSE3.SA cash_flow (quarterly, 2025-12-31) — Deferred Tax: -6616000.00
CXSE3.SA income_statement (annual, 2025-12-31) — Diluted Average Shares: 2980277778.00
CXSE3.SA income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 2897297297.00
CXSE3.SA income_statement (annual, 2025-12-31) — Diluted EPS: 1.44
CXSE3.SA income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.37
CXSE3.SA income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 4291560000.00
CXSE3.SA income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 1071979000.00
CXSE3.SA cash_flow (annual, 2025-12-31) — Dividend Received Cfo: 3631760000.00
CXSE3.SA cash_flow (quarterly, 2025-12-31) — Dividend Received Cfo: 1639493000.00
CXSE3.SA balance_sheet (annual, 2025-12-31) — Dividends Payable: 1050008000.00
CXSE3.SA balance_sheet (quarterly, 2025-12-31) — Dividends Payable: 1050008000.00
CXSE3.SA cash_flow (annual, 2025-12-31) — End Cash Position: 88000.00
CXSE3.SA cash_flow (quarterly, 2025-12-31) — End Cash Position: 88000.00
CXSE3.SA balance_sheet (annual, 2025-12-31) — Financial Assets: 0.00
CXSE3.SA balance_sheet (quarterly, 2025-12-31) — Financial Assets: 0.00
CXSE3.SA cash_flow (annual, 2025-12-31) — Financing Cash Flow: -3241014000.00
CXSE3.SA cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -415025000.00
CXSE3.SA cash_flow (annual, 2025-12-31) — Free Cash Flow: 3840433000.00
CXSE3.SA cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 1120167000.00
CXSE3.SA income_statement (annual, 2025-12-31) — General And Administrative Expense: 36529000.00
CXSE3.SA income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 11132000.00
CXSE3.SA balance_sheet (annual, 2025-12-31) — Gross PPE: 9668000.00
CXSE3.SA balance_sheet (quarterly, 2025-12-31) — Gross PPE: 9668000.00
CXSE3.SA income_statement (annual, 2025-12-31) — Interest Income: 529000.00
CXSE3.SA income_statement (annual, 2025-12-31) — Interest Income Non Operating: 529000.00
CXSE3.SA cash_flow (annual, 2025-12-31) — Interest Received Cfo: 0.00
CXSE3.SA cash_flow (quarterly, 2025-12-31) — Interest Received Cfo: -21092000.00
CXSE3.SA balance_sheet (annual, 2025-12-31) — Invested Capital: 13550484000.00
CXSE3.SA balance_sheet (quarterly, 2025-12-31) — Invested Capital: 13550484000.00
CXSE3.SA cash_flow (annual, 2025-12-31) — Investing Cash Flow: -599412000.00
CXSE3.SA cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -704904000.00
CXSE3.SA balance_sheet (annual, 2025-12-31) — Investments And Advances: 14246435000.00
CXSE3.SA balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 14246435000.00
CXSE3.SA balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 12708995000.00
CXSE3.SA balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 12708995000.00
CXSE3.SA income_statement (annual, 2025-12-31) — Net Income: 4291560000.00
CXSE3.SA income_statement (quarterly, 2025-12-31) — Net Income: 1071979000.00
CXSE3.SA income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 4291560000.00
CXSE3.SA income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 1071979000.00
CXSE3.SA income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 4291560000.00
CXSE3.SA income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 1071979000.00
CXSE3.SA income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 4291560000.00
CXSE3.SA income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 1071979000.00
CXSE3.SA income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 4291560000.00
CXSE3.SA income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 1071979000.00
CXSE3.SA cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 3765184000.00
CXSE3.SA cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 545603000.00
CXSE3.SA income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 4291560000.00
CXSE3.SA income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 1071979000.00
CXSE3.SA income_statement (annual, 2025-12-31) — Net Interest Income: 182274000.00
CXSE3.SA income_statement (quarterly, 2025-12-31) — Net Interest Income: 57878000.00
CXSE3.SA cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -599412000.00
CXSE3.SA cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -704904000.00
CXSE3.SA income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 182274000.00
CXSE3.SA income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 57878000.00
CXSE3.SA balance_sheet (annual, 2025-12-31) — Net PPE: 9668000.00
CXSE3.SA balance_sheet (quarterly, 2025-12-31) — Net PPE: 9668000.00
CXSE3.SA balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 13550484000.00
CXSE3.SA balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 13550484000.00
CXSE3.SA balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 0.00
CXSE3.SA balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 0.00
CXSE3.SA income_statement (annual, 2025-12-31) — Normalized Income: 4291560000.00
CXSE3.SA income_statement (quarterly, 2025-12-31) — Normalized Income: 1071979000.00
CXSE3.SA cash_flow (annual, 2025-12-31) — Operating Cash Flow: 3840433000.00
CXSE3.SA cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 1120167000.00
CXSE3.SA income_statement (annual, 2025-12-31) — Operating Revenue: 2458103000.00
CXSE3.SA income_statement (quarterly, 2025-12-31) — Operating Revenue: 622432000.00
CXSE3.SA balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 3000000000.00
CXSE3.SA balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 3000000000.00
CXSE3.SA balance_sheet (annual, 2025-12-31) — Other Equity Interest: 5430281000.00
CXSE3.SA balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 5430281000.00
CXSE3.SA income_statement (annual, 2025-12-31) — Other Income Expense: 202778000.00
CXSE3.SA income_statement (quarterly, 2025-12-31) — Other Income Expense: 60846000.00
CXSE3.SA cash_flow (annual, 2025-12-31) — Other Non Cash Items: 3000.00
CXSE3.SA cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -881000.00
CXSE3.SA income_statement (annual, 2025-12-31) — Other Operating Expenses: 321746000.00
CXSE3.SA income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 84771000.00
CXSE3.SA balance_sheet (annual, 2025-12-31) — Other Properties: 9668000.00
CXSE3.SA balance_sheet (quarterly, 2025-12-31) — Other Properties: 9668000.00
CXSE3.SA balance_sheet (annual, 2025-12-31) — Other Receivables: 185056000.00
CXSE3.SA balance_sheet (quarterly, 2025-12-31) — Other Receivables: 185056000.00
CXSE3.SA balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 1537440000.00
CXSE3.SA balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 1537440000.00
CXSE3.SA balance_sheet (annual, 2025-12-31) — Payables: 1214000000.00
CXSE3.SA balance_sheet (quarterly, 2025-12-31) — Payables: 1214000000.00
CXSE3.SA income_statement (annual, 2025-12-31) — Pretax Income: 4829789000.00
CXSE3.SA income_statement (quarterly, 2025-12-31) — Pretax Income: 1206717000.00
CXSE3.SA cash_flow (annual, 2025-12-31) — Purchase Of Investment: -3458408000.00
CXSE3.SA cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: 18603169000.00
CXSE3.SA income_statement (annual, 2025-12-31) — Rent And Landing Fees: 826000.00
CXSE3.SA income_statement (annual, 2025-12-31) — Rent Expense Supplemental: 826000.00
CXSE3.SA cash_flow (annual, 2025-12-31) — Sale Of Investment: 2858996000.00
CXSE3.SA cash_flow (quarterly, 2025-12-31) — Sale Of Investment: -19308073000.00
CXSE3.SA income_statement (annual, 2025-12-31) — Selling General And Administration: 36529000.00
CXSE3.SA income_statement (quarterly, 2025-12-31) — Selling General And Administration: 11132000.00
CXSE3.SA balance_sheet (annual, 2025-12-31) — Share Issued: 3000000000.00
CXSE3.SA balance_sheet (quarterly, 2025-12-31) — Share Issued: 3000000000.00
CXSE3.SA balance_sheet (annual, 2025-12-31) — Stockholders Equity: 13550484000.00
CXSE3.SA balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 13550484000.00
CXSE3.SA balance_sheet (annual, 2025-12-31) — Tangible Book Value: 13550484000.00
CXSE3.SA balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 13550484000.00
CXSE3.SA income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CXSE3.SA income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CXSE3.SA income_statement (annual, 2025-12-31) — Tax Provision: 538229000.00
CXSE3.SA income_statement (quarterly, 2025-12-31) — Tax Provision: 134738000.00
CXSE3.SA income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.11
CXSE3.SA income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.11
CXSE3.SA balance_sheet (annual, 2025-12-31) — Taxes Receivable: 1871000.00
CXSE3.SA balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 1871000.00
CXSE3.SA balance_sheet (annual, 2025-12-31) — Total Assets: 14765001000.00
CXSE3.SA balance_sheet (quarterly, 2025-12-31) — Total Assets: 14765001000.00
CXSE3.SA balance_sheet (annual, 2025-12-31) — Total Capitalization: 13550484000.00
CXSE3.SA balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 13550484000.00
CXSE3.SA balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 13550484000.00
CXSE3.SA balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 13550484000.00
CXSE3.SA income_statement (annual, 2025-12-31) — Total Expenses: -2371686000.00
CXSE3.SA income_statement (quarterly, 2025-12-31) — Total Expenses: -584285000.00
CXSE3.SA balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 1214517000.00
CXSE3.SA balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 1214517000.00
CXSE3.SA income_statement (annual, 2025-12-31) — Total Other Finance Cost: -181745000.00
CXSE3.SA income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: -57349000.00
CXSE3.SA balance_sheet (annual, 2025-12-31) — Total Tax Payable: 70406000.00
CXSE3.SA balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 70406000.00
CXSE3.SA income_statement (quarterly, 2026-03-31) — +Total Revenue: 620529000.00
CXSE3.SA balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 86710000.00
CXSE3.SA balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 149591000.00
CXSE3.SA income_statement (quarterly, 2026-03-31) — Basic Average Shares: 3000000000.00
CXSE3.SA income_statement (quarterly, 2026-03-31) — Basic EPS: 0.38
CXSE3.SA cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 306000.00
CXSE3.SA balance_sheet (quarterly, 2026-03-31) — Capital Stock: 3678772000.00
CXSE3.SA balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 364000.00
CXSE3.SA balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 1076427000.00
CXSE3.SA cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -1056165000.00
CXSE3.SA cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -785000.00
CXSE3.SA cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: 3891000.00
CXSE3.SA cash_flow (quarterly, 2026-03-31) — Change In Payable: 1352000.00
CXSE3.SA cash_flow (quarterly, 2026-03-31) — Change In Receivables: 12670000.00
CXSE3.SA cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 17128000.00
CXSE3.SA cash_flow (quarterly, 2026-03-31) — Changes In Cash: 58000.00
CXSE3.SA balance_sheet (quarterly, 2026-03-31) — Common Stock: 3678772000.00
CXSE3.SA cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -1056165000.00
CXSE3.SA balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 13772009000.00
CXSE3.SA balance_sheet (quarterly, 2026-03-31) — Current Deferred Taxes Assets: 115000.00
CXSE3.SA balance_sheet (quarterly, 2026-03-31) — Current Deferred Taxes Liabilities: 4390000.00
CXSE3.SA cash_flow (quarterly, 2026-03-31) — Deferred Tax: 2898000.00
CXSE3.SA income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 3000000000.00
CXSE3.SA income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.38
CXSE3.SA income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 1150278000.00
CXSE3.SA cash_flow (quarterly, 2026-03-31) — Dividend Received Cfo: 209094000.00
CXSE3.SA balance_sheet (quarterly, 2026-03-31) — Dividends Payable: 990008000.00
CXSE3.SA income_statement (quarterly, 2026-03-31) — EBIT: 1281085000.00
CXSE3.SA cash_flow (quarterly, 2026-03-31) — End Cash Position: 364000.00
CXSE3.SA balance_sheet (quarterly, 2026-03-31) — Financial Assets: 66000.00
CXSE3.SA cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -1056648000.00
CXSE3.SA cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 469743000.00
CXSE3.SA income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 11338000.00
CXSE3.SA balance_sheet (quarterly, 2026-03-31) — Gross PPE: 9128000.00
CXSE3.SA income_statement (quarterly, 2026-03-31) — Interest Expense: 685000.00
CXSE3.SA income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 685000.00
CXSE3.SA income_statement (quarterly, 2026-03-31) — Interest Income: 0.00
CXSE3.SA income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 0.00
CXSE3.SA balance_sheet (quarterly, 2026-03-31) — Invested Capital: 13772009000.00
CXSE3.SA cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 586963000.00
CXSE3.SA balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 66000.00
CXSE3.SA balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 13872381000.00
CXSE3.SA balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 12796252000.00
CXSE3.SA income_statement (quarterly, 2026-03-31) — Net Income: 1150278000.00
CXSE3.SA income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 1150278000.00
CXSE3.SA income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 1150278000.00
CXSE3.SA income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 1150278000.00
CXSE3.SA income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 1150278000.00
CXSE3.SA cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 1150278000.00
CXSE3.SA income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 1150278000.00
CXSE3.SA income_statement (quarterly, 2026-03-31) — Net Interest Income: 28825000.00
CXSE3.SA cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 586963000.00
CXSE3.SA income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 28825000.00
CXSE3.SA balance_sheet (quarterly, 2026-03-31) — Net PPE: 9128000.00
CXSE3.SA balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 13772009000.00
CXSE3.SA balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 0.00
CXSE3.SA income_statement (quarterly, 2026-03-31) — Normalized Income: 1150278000.00
CXSE3.SA cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 469743000.00
CXSE3.SA income_statement (quarterly, 2026-03-31) — Operating Revenue: 620529000.00
CXSE3.SA balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 3000000000.00
CXSE3.SA balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 5491528000.00
CXSE3.SA income_statement (quarterly, 2026-03-31) — Other Income Expense: 41891000.00
CXSE3.SA cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 699000.00
CXSE3.SA income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 79266000.00
CXSE3.SA balance_sheet (quarterly, 2026-03-31) — Other Properties: 9128000.00
CXSE3.SA balance_sheet (quarterly, 2026-03-31) — Other Receivables: 860305000.00
CXSE3.SA balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 1076063000.00
CXSE3.SA balance_sheet (quarterly, 2026-03-31) — Payables: 1148862000.00
CXSE3.SA income_statement (quarterly, 2026-03-31) — Pretax Income: 1280400000.00
CXSE3.SA cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -4037721000.00
CXSE3.SA balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 1150278000.00
CXSE3.SA cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 4624684000.00
CXSE3.SA income_statement (quarterly, 2026-03-31) — Selling General And Administration: 11338000.00
CXSE3.SA balance_sheet (quarterly, 2026-03-31) — Share Issued: 3000000000.00
CXSE3.SA balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 13772009000.00
CXSE3.SA balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 13772009000.00
CXSE3.SA income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
CXSE3.SA income_statement (quarterly, 2026-03-31) — Tax Provision: 130122000.00
CXSE3.SA income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.10
CXSE3.SA balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 107000.00
CXSE3.SA balance_sheet (quarterly, 2026-03-31) — Total Assets: 14925261000.00
CXSE3.SA balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 13772009000.00
CXSE3.SA balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 13772009000.00
CXSE3.SA income_statement (quarterly, 2026-03-31) — Total Expenses: -659871000.00
CXSE3.SA balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 1153252000.00
CXSE3.SA income_statement (quarterly, 2026-03-31) — Total Other Finance Cost: -29510000.00
CXSE3.SA balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 72144000.00
CXT balance_sheet (annual, 2021-12-31) — Commercial Paper: 0.00
CXT cash_flow (annual, 2021-12-31) — Common Stock Payments: -96300000.00
CXT cash_flow (annual, 2021-12-31) — Earnings Losses From Equity Investments: 0.00
CXT cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of Business: 0.00
CXT cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of PPE: -18500000.00
CXT income_statement (annual, 2021-12-31) — Gain On Sale Of Business: 0.00
CXT balance_sheet (annual, 2021-12-31) — Minority Interest: 2800000.00
CXT cash_flow (annual, 2021-12-31) — Net Common Stock Issuance: -96300000.00
CXT cash_flow (annual, 2021-12-31) — Net PPE Purchase And Sale: 2800000.00
CXT cash_flow (annual, 2021-12-31) — Net Short Term Debt Issuance: 0.00
CXT balance_sheet (annual, 2021-12-31) — Non Current Accounts Receivable: 60000000.00
CXT balance_sheet (annual, 2021-12-31) — Other Current Liabilities: 62300000.00
CXT balance_sheet (annual, 2021-12-31) — Other Receivables: 13700000.00
CXT cash_flow (annual, 2021-12-31) — Provisionand Write Offof Assets: 0.00
CXT cash_flow (annual, 2021-12-31) — Repurchase Of Capital Stock: -96300000.00
CXT cash_flow (annual, 2021-12-31) — Sale Of Business: 0.00
CXT cash_flow (annual, 2021-12-31) — Sale Of Investment: 40000000.00
CXT cash_flow (annual, 2021-12-31) — Sale Of PPE: 2800000.00
CXT income_statement (annual, 2021-12-31) — Selling And Marketing Expense: 775400000.00
CXT cash_flow (annual, 2021-12-31) — Short Term Debt Issuance: 0.00
CXT cash_flow (annual, 2021-12-31) — Short Term Debt Payments: 0.00
CXT income_statement (annual, 2022-12-31) — +Operating Expense: 318700000.00
CXT income_statement (annual, 2022-12-31) — +Total Revenue: 1339900000.00
CXT balance_sheet (annual, 2022-12-31) — Accounts Payable: 109600000.00
CXT balance_sheet (annual, 2022-12-31) — Accounts Receivable: 205100000.00
CXT balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -259900000.00
CXT balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 0.00
CXT balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -6100000.00
CXT income_statement (annual, 2022-12-31) — Basic Average Shares: 56725307.00
CXT income_statement (annual, 2022-12-31) — Basic EPS: 3.61
CXT cash_flow (annual, 2022-12-31) — Beginning Cash Position: 101200000.00
CXT balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 117300000.00
CXT cash_flow (annual, 2022-12-31) — Capital Expenditure: -21300000.00
CXT cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -21300000.00
CXT balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 36400000.00
CXT balance_sheet (annual, 2022-12-31) — Capital Stock: 0.00
CXT balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 230700000.00
CXT balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 230700000.00
CXT cash_flow (annual, 2022-12-31) — Cash Dividends Paid: 0.00
CXT cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -135000000.00
CXT cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -21300000.00
CXT cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 306000000.00
CXT cash_flow (annual, 2022-12-31) — Change In Account Payable: 13900000.00
CXT cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 34400000.00
CXT cash_flow (annual, 2022-12-31) — Change In Income Tax Payable: 4000000.00
CXT cash_flow (annual, 2022-12-31) — Change In Inventory: -12700000.00
CXT cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -600000.00
CXT cash_flow (annual, 2022-12-31) — Change In Payable: 17900000.00
CXT cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 52300000.00
CXT cash_flow (annual, 2022-12-31) — Change In Receivables: 300000.00
CXT cash_flow (annual, 2022-12-31) — Change In Tax Payable: 4000000.00
CXT cash_flow (annual, 2022-12-31) — Change In Working Capital: 39300000.00
CXT cash_flow (annual, 2022-12-31) — Changes In Account Receivables: 300000.00
CXT cash_flow (annual, 2022-12-31) — Changes In Cash: 149700000.00
CXT balance_sheet (annual, 2022-12-31) — Common Stock: 0.00
CXT cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: 0.00
CXT balance_sheet (annual, 2022-12-31) — Common Stock Equity: 783800000.00
CXT cash_flow (annual, 2022-12-31) — Common Stock Payments: -203700000.00
CXT income_statement (annual, 2022-12-31) — Cost Of Revenue: 713700000.00
CXT balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 46900000.00
CXT balance_sheet (annual, 2022-12-31) — Current Assets: 623300000.00
CXT balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 7400000.00
CXT balance_sheet (annual, 2022-12-31) — Current Debt: 299700000.00
CXT balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 307100000.00
CXT balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 93600000.00
CXT balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 93600000.00
CXT balance_sheet (annual, 2022-12-31) — Current Liabilities: 631400000.00
CXT cash_flow (annual, 2022-12-31) — Deferred Income Tax: -28400000.00
CXT cash_flow (annual, 2022-12-31) — Deferred Tax: -28400000.00
CXT cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 78700000.00
CXT cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 78700000.00
CXT income_statement (annual, 2022-12-31) — Diluted Average Shares: 56725307.00
CXT income_statement (annual, 2022-12-31) — Diluted EPS: 3.61
CXT income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 204900000.00
CXT income_statement (annual, 2022-12-31) — EBIT: 304600000.00
CXT income_statement (annual, 2022-12-31) — EBITDA: 383300000.00
CXT cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -20200000.00
CXT balance_sheet (annual, 2022-12-31) — Employee Benefits: 21100000.00
CXT cash_flow (annual, 2022-12-31) — End Cash Position: 230700000.00
CXT cash_flow (annual, 2022-12-31) — Financing Cash Flow: -135000000.00
CXT balance_sheet (annual, 2022-12-31) — Finished Goods: 49200000.00
CXT cash_flow (annual, 2022-12-31) — Free Cash Flow: 284700000.00
CXT cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: -232500000.00
CXT cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: -2800000.00
CXT income_statement (annual, 2022-12-31) — Gain On Sale Of Business: 232500000.00
CXT balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -131500000.00
CXT balance_sheet (annual, 2022-12-31) — Goodwill: 836600000.00
CXT balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 1181500000.00
CXT balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 211200000.00
CXT balance_sheet (annual, 2022-12-31) — Gross PPE: 521500000.00
CXT income_statement (annual, 2022-12-31) — Gross Profit: 626200000.00
CXT cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 63500000.00
CXT balance_sheet (annual, 2022-12-31) — Income Tax Payable: 17900000.00
CXT income_statement (annual, 2022-12-31) — Interest Expense: 56300000.00
CXT income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 56300000.00
CXT income_statement (annual, 2022-12-31) — Interest Income: 200000.00
CXT income_statement (annual, 2022-12-31) — Interest Income Non Operating: 200000.00
CXT cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 41200000.00
CXT balance_sheet (annual, 2022-12-31) — Interest Payable: 6500000.00
CXT balance_sheet (annual, 2022-12-31) — Inventory: 145600000.00
CXT balance_sheet (annual, 2022-12-31) — Invested Capital: 1628600000.00
CXT cash_flow (annual, 2022-12-31) — Investing Cash Flow: -21300000.00
CXT cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
CXT balance_sheet (annual, 2022-12-31) — Land And Improvements: 31000000.00
CXT balance_sheet (annual, 2022-12-31) — Line Of Credit: 399600000.00
CXT balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 29000000.00
CXT balance_sheet (annual, 2022-12-31) — Long Term Debt: 545100000.00
CXT balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 574100000.00
CXT cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
CXT cash_flow (annual, 2022-12-31) — Long Term Debt Payments: 0.00
CXT balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 373200000.00
CXT balance_sheet (annual, 2022-12-31) — Minority Interest: 2600000.00
CXT income_statement (annual, 2022-12-31) — Minority Interests: 0.00
CXT cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 0.00
CXT cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -203700000.00
CXT balance_sheet (annual, 2022-12-31) — Net Debt: 614100000.00
CXT income_statement (annual, 2022-12-31) — Net Income: 204900000.00
CXT income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 204900000.00
CXT income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 204900000.00
CXT income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 204900000.00
CXT income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 204900000.00
CXT cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 204900000.00
CXT income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 204900000.00
CXT income_statement (annual, 2022-12-31) — Net Interest Income: -56100000.00
CXT cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 0.00
CXT cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 0.00
CXT cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 0.00
CXT income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -56100000.00
CXT cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -135000000.00
CXT balance_sheet (annual, 2022-12-31) — Net PPE: 261600000.00
CXT cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: 4300000.00
CXT cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 0.00
CXT balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -397700000.00
CXT balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 6300000.00
CXT balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 109500000.00
CXT balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 6300000.00
CXT balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 109500000.00
CXT balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 21100000.00
CXT income_statement (annual, 2022-12-31) — Normalized EBITDA: 389500000.00
CXT income_statement (annual, 2022-12-31) — Normalized Income: 210015000.00
CXT cash_flow (annual, 2022-12-31) — Operating Cash Flow: 306000000.00
CXT cash_flow (annual, 2022-12-31) — Operating Gains Losses: -300000.00
CXT income_statement (annual, 2022-12-31) — Operating Income: 307500000.00
CXT income_statement (annual, 2022-12-31) — Operating Revenue: 1339900000.00
CXT balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 56725307.00
CXT balance_sheet (annual, 2022-12-31) — Other Current Assets: 41900000.00
CXT balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 299700000.00
CXT balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -131500000.00
CXT balance_sheet (annual, 2022-12-31) — Other Equity Interest: 915300000.00
CXT income_statement (annual, 2022-12-31) — Other Income Expense: -3100000.00
CXT balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 344900000.00
CXT cash_flow (annual, 2022-12-31) — Other Non Cash Items: 2500000.00
CXT balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 56700000.00
CXT balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 1400000.00
CXT income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 3100000.00
CXT income_statement (annual, 2022-12-31) — Other Special Charges: 162400000.00
CXT balance_sheet (annual, 2022-12-31) — Payables: 127500000.00
CXT balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 174400000.00
CXT cash_flow (annual, 2022-12-31) — Pension And Employee Benefit Expense: -300000.00
CXT balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 56300000.00
CXT balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
CXT income_statement (annual, 2022-12-31) — Pretax Income: 248300000.00
CXT cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 0.00
CXT balance_sheet (annual, 2022-12-31) — Properties: 0.00
CXT cash_flow (annual, 2022-12-31) — Purchase Of Business: 0.00
CXT cash_flow (annual, 2022-12-31) — Purchase Of Investment: 0.00
CXT balance_sheet (annual, 2022-12-31) — Raw Materials: 83700000.00
CXT balance_sheet (annual, 2022-12-31) — Receivables: 205100000.00
CXT income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 713700000.00
CXT income_statement (annual, 2022-12-31) — Reconciled Depreciation: 78700000.00
CXT cash_flow (annual, 2022-12-31) — Repayment Of Debt: 0.00
CXT cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -203700000.00
CXT income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 6200000.00
CXT balance_sheet (annual, 2022-12-31) — Retained Earnings: 0.00
CXT cash_flow (annual, 2022-12-31) — Sale Of Business: 318100000.00
CXT cash_flow (annual, 2022-12-31) — Sale Of Investment: 0.00
CXT cash_flow (annual, 2022-12-31) — Sale Of PPE: 4300000.00
CXT income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 797500000.00
CXT income_statement (annual, 2022-12-31) — Selling General And Administration: 318700000.00
CXT balance_sheet (annual, 2022-12-31) — Share Issued: 56725307.00
CXT cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 0.00
CXT cash_flow (annual, 2022-12-31) — Short Term Debt Payments: 0.00
CXT income_statement (annual, 2022-12-31) — Special Income Charges: -6200000.00
CXT cash_flow (annual, 2022-12-31) — Stock Based Compensation: 9300000.00
CXT balance_sheet (annual, 2022-12-31) — Stockholders Equity: 783800000.00
CXT balance_sheet (annual, 2022-12-31) — Tangible Book Value: -397700000.00
CXT income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -1085000.00
CXT income_statement (annual, 2022-12-31) — Tax Provision: 43400000.00
CXT income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.18
CXT balance_sheet (annual, 2022-12-31) — Total Assets: 2129400000.00
CXT balance_sheet (annual, 2022-12-31) — Total Capitalization: 1328900000.00
CXT balance_sheet (annual, 2022-12-31) — Total Debt: 881200000.00
CXT balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 783800000.00
CXT income_statement (annual, 2022-12-31) — Total Expenses: 1032400000.00
CXT balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 1345600000.00
CXT balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 1506100000.00
CXT balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 714200000.00
CXT income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 301300000.00
CXT balance_sheet (annual, 2022-12-31) — Total Tax Payable: 17900000.00
CXT income_statement (annual, 2022-12-31) — Total Unusual Items: -6200000.00
CXT income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -6200000.00
CXT balance_sheet (annual, 2022-12-31) — Tradeand Other Payables Non Current: 8100000.00
CXT balance_sheet (annual, 2022-12-31) — Treasury Stock: 0.00
CXT balance_sheet (annual, 2022-12-31) — Work In Process: 12700000.00
CXT balance_sheet (annual, 2022-12-31) — Working Capital: -8100000.00
CXT income_statement (annual, 2023-12-31) — +Operating Expense: 366800000.00
CXT income_statement (annual, 2023-12-31) — +Total Revenue: 1391300000.00
CXT balance_sheet (annual, 2023-12-31) — Accounts Payable: 106500000.00
CXT balance_sheet (annual, 2023-12-31) — Accounts Receivable: 214900000.00
CXT balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -302900000.00
CXT balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 1728100000.00
CXT balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -11800000.00
CXT income_statement (annual, 2023-12-31) — Basic Average Shares: 56800000.00
CXT income_statement (annual, 2023-12-31) — Basic EPS: 3.32
CXT cash_flow (annual, 2023-12-31) — Beginning Cash Position: 230700000.00
CXT balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 123200000.00
CXT cash_flow (annual, 2023-12-31) — Capital Expenditure: -31100000.00
CXT cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -31100000.00
CXT balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 49800000.00
CXT balance_sheet (annual, 2023-12-31) — Capital Stock: 72400000.00
CXT balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 227200000.00
CXT balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 227200000.00
CXT cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -23700000.00
CXT cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -252500000.00
CXT cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -31100000.00
CXT cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 276300000.00
CXT cash_flow (annual, 2023-12-31) — Change In Account Payable: -6800000.00
CXT cash_flow (annual, 2023-12-31) — Change In Accrued Expense: -2500000.00
CXT cash_flow (annual, 2023-12-31) — Change In Income Tax Payable: 16600000.00
CXT cash_flow (annual, 2023-12-31) — Change In Inventory: -1000000.00
CXT cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 0.00
CXT cash_flow (annual, 2023-12-31) — Change In Payable: 9800000.00
CXT cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 7300000.00
CXT cash_flow (annual, 2023-12-31) — Change In Receivables: -6300000.00
CXT cash_flow (annual, 2023-12-31) — Change In Tax Payable: 16600000.00
CXT cash_flow (annual, 2023-12-31) — Change In Working Capital: 0.00
CXT cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -6300000.00
CXT cash_flow (annual, 2023-12-31) — Changes In Cash: -7300000.00
CXT balance_sheet (annual, 2023-12-31) — Common Stock: 72400000.00
CXT cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -23700000.00
CXT balance_sheet (annual, 2023-12-31) — Common Stock Equity: 964000000.00
CXT income_statement (annual, 2023-12-31) — Cost Of Revenue: 737200000.00
CXT balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 48500000.00
CXT balance_sheet (annual, 2023-12-31) — Current Assets: 644400000.00
CXT balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 7200000.00
CXT balance_sheet (annual, 2023-12-31) — Current Debt: 4600000.00
CXT balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 11800000.00
CXT balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 92500000.00
CXT balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 92500000.00
CXT balance_sheet (annual, 2023-12-31) — Current Liabilities: 334400000.00
CXT cash_flow (annual, 2023-12-31) — Deferred Income Tax: 7600000.00
CXT cash_flow (annual, 2023-12-31) — Deferred Tax: 7600000.00
CXT cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 77600000.00
CXT cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 77600000.00
CXT income_statement (annual, 2023-12-31) — Diluted Average Shares: 57500000.00
CXT income_statement (annual, 2023-12-31) — Diluted EPS: 3.28
CXT income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 188300000.00
CXT income_statement (annual, 2023-12-31) — EBIT: 290400000.00
CXT income_statement (annual, 2023-12-31) — EBITDA: 368000000.00
CXT income_statement (annual, 2023-12-31) — Earnings From Equity Interest: 0.00
CXT cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: 0.00
CXT cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 3800000.00
CXT balance_sheet (annual, 2023-12-31) — Employee Benefits: 22500000.00
CXT cash_flow (annual, 2023-12-31) — End Cash Position: 227200000.00
CXT cash_flow (annual, 2023-12-31) — Financing Cash Flow: -252500000.00
CXT balance_sheet (annual, 2023-12-31) — Finished Goods: 58300000.00
CXT cash_flow (annual, 2023-12-31) — Free Cash Flow: 245200000.00
CXT balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -118600000.00
CXT balance_sheet (annual, 2023-12-31) — Goodwill: 841200000.00
CXT balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 1150100000.00
CXT balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 226700000.00
CXT balance_sheet (annual, 2023-12-31) — Gross PPE: 564100000.00
CXT income_statement (annual, 2023-12-31) — Gross Profit: 654100000.00
CXT cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 46000000.00
CXT balance_sheet (annual, 2023-12-31) — Income Tax Payable: 12800000.00
CXT income_statement (annual, 2023-12-31) — Interest Expense: 50600000.00
CXT income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 50600000.00
CXT income_statement (annual, 2023-12-31) — Interest Income: 1100000.00
CXT income_statement (annual, 2023-12-31) — Interest Income Non Operating: 1100000.00
CXT cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 45100000.00
CXT balance_sheet (annual, 2023-12-31) — Interest Payable: 6300000.00
CXT balance_sheet (annual, 2023-12-31) — Inventory: 157100000.00
CXT balance_sheet (annual, 2023-12-31) — Invested Capital: 1608900000.00
CXT cash_flow (annual, 2023-12-31) — Investing Cash Flow: -31100000.00
CXT cash_flow (annual, 2023-12-31) — Issuance Of Debt: 370000000.00
CXT balance_sheet (annual, 2023-12-31) — Land And Improvements: 34800000.00
CXT balance_sheet (annual, 2023-12-31) — Line Of Credit: 0.00
CXT balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 42600000.00
CXT balance_sheet (annual, 2023-12-31) — Long Term Debt: 640300000.00
CXT balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 682900000.00
CXT cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 370000000.00
CXT cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -565000000.00
CXT balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 406100000.00
CXT income_statement (annual, 2023-12-31) — Minority Interests: 0.00
CXT cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 0.00
CXT balance_sheet (annual, 2023-12-31) — Net Debt: 417700000.00
CXT income_statement (annual, 2023-12-31) — Net Income: 188300000.00
CXT income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 188300000.00
CXT income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 188300000.00
CXT income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 188300000.00
CXT income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 188300000.00
CXT cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 188300000.00
CXT income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 188300000.00
CXT income_statement (annual, 2023-12-31) — Net Interest Income: -49500000.00
CXT cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 0.00
CXT cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -195000000.00
CXT cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -195000000.00
CXT income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -49500000.00
CXT cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -38800000.00
CXT balance_sheet (annual, 2023-12-31) — Net PPE: 261200000.00
CXT cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: 0.00
CXT cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: 0.00
CXT balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -186100000.00
CXT balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 2700000.00
CXT balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 104500000.00
CXT balance_sheet (annual, 2023-12-31) — Non Current Deferred Revenue: 0.00
CXT balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 2700000.00
CXT balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 104500000.00
CXT balance_sheet (annual, 2023-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 22500000.00
CXT income_statement (annual, 2023-12-31) — Normalized EBITDA: 368500000.00
CXT income_statement (annual, 2023-12-31) — Normalized Income: 188692618.85
CXT cash_flow (annual, 2023-12-31) — Operating Cash Flow: 276300000.00
CXT cash_flow (annual, 2023-12-31) — Operating Gains Losses: -1100000.00
CXT income_statement (annual, 2023-12-31) — Operating Income: 287300000.00
CXT income_statement (annual, 2023-12-31) — Operating Revenue: 1391300000.00
CXT balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 56897457.00
CXT balance_sheet (annual, 2023-12-31) — Other Current Assets: 45200000.00
CXT balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 4600000.00
CXT balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -118600000.00
CXT income_statement (annual, 2023-12-31) — Other Income Expense: 2000000.00
CXT balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 308900000.00
CXT cash_flow (annual, 2023-12-31) — Other Non Cash Items: -6400000.00
CXT balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 71000000.00
CXT balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 1800000.00
CXT income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 2500000.00
CXT balance_sheet (annual, 2023-12-31) — Payables: 119300000.00
CXT balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 167800000.00
CXT cash_flow (annual, 2023-12-31) — Pension And Employee Benefit Expense: -1100000.00
CXT balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 62300000.00
CXT balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
CXT income_statement (annual, 2023-12-31) — Pretax Income: 239800000.00
CXT cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 5000000.00
CXT balance_sheet (annual, 2023-12-31) — Properties: 0.00
CXT cash_flow (annual, 2023-12-31) — Purchase Of Business: 0.00
CXT cash_flow (annual, 2023-12-31) — Purchase Of Investment: 0.00
CXT balance_sheet (annual, 2023-12-31) — Raw Materials: 92400000.00
CXT balance_sheet (annual, 2023-12-31) — Receivables: 214900000.00
CXT income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 737200000.00
CXT income_statement (annual, 2023-12-31) — Reconciled Depreciation: 77600000.00
CXT cash_flow (annual, 2023-12-31) — Repayment Of Debt: -565000000.00
CXT income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 500000.00
CXT balance_sheet (annual, 2023-12-31) — Retained Earnings: 120900000.00
CXT cash_flow (annual, 2023-12-31) — Sale Of PPE: 0.00
CXT income_statement (annual, 2023-12-31) — Selling General And Administration: 366800000.00
CXT balance_sheet (annual, 2023-12-31) — Share Issued: 72441647.00
CXT cash_flow (annual, 2023-12-31) — Short Term Debt Issuance: 20000000.00
CXT cash_flow (annual, 2023-12-31) — Short Term Debt Payments: -20000000.00
CXT income_statement (annual, 2023-12-31) — Special Income Charges: -500000.00
CXT cash_flow (annual, 2023-12-31) — Stock Based Compensation: 10300000.00
CXT balance_sheet (annual, 2023-12-31) — Stockholders Equity: 964000000.00
CXT balance_sheet (annual, 2023-12-31) — Tangible Book Value: -186100000.00
CXT income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -107381.15
CXT income_statement (annual, 2023-12-31) — Tax Provision: 51500000.00
CXT income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.21
CXT balance_sheet (annual, 2023-12-31) — Taxes Receivable: 0.00
CXT balance_sheet (annual, 2023-12-31) — Total Assets: 2129400000.00
CXT balance_sheet (annual, 2023-12-31) — Total Capitalization: 1604300000.00
CXT balance_sheet (annual, 2023-12-31) — Total Debt: 694700000.00
CXT balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 964000000.00
CXT income_statement (annual, 2023-12-31) — Total Expenses: 1104000000.00
CXT balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 1165400000.00
CXT balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 1485000000.00
CXT balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 831000000.00
CXT income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 286800000.00
CXT balance_sheet (annual, 2023-12-31) — Total Tax Payable: 12800000.00
CXT income_statement (annual, 2023-12-31) — Total Unusual Items: -500000.00
CXT income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -500000.00
CXT balance_sheet (annual, 2023-12-31) — Tradeand Other Payables Non Current: 19300000.00
CXT balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 15544190.00
CXT balance_sheet (annual, 2023-12-31) — Treasury Stock: 838800000.00
CXT balance_sheet (annual, 2023-12-31) — Work In Process: 6400000.00
CXT balance_sheet (annual, 2023-12-31) — Working Capital: 310000000.00
CXT cash_flow (quarterly, 2024-09-30) — Net Investment Purchase And Sale: 0.00
CXT cash_flow (quarterly, 2024-09-30) — Net Short Term Debt Issuance: -65000000.00
CXT cash_flow (quarterly, 2024-09-30) — Operating Gains Losses: -1800000.00